DBS was approved in the United States by the Food and Drug Administration for the treatment of Parkinson's in 2002. DBS carries the risks of major surgery, with a complication rate related to the experience of the surgical team. The major complications include hemorrhage (1–2%) and infection (3–5%).
d iː b iː ɛ s WORD_BOUNDARY w ʌ z WORD_BOUNDARY ʌ p ɹ uː v d WORD_BOUNDARY ɪ n ð ə WORD_BOUNDARY j uː n aɪ t ɪ d WORD_BOUNDARY s t eɪ t s WORD_BOUNDARY b aɪ WORD_BOUNDARY ð ə WORD_BOUNDARY f uː d WORD_BOUNDARY æ n d WORD_BOUNDARY d ɹ ʌ ɡ WORD_BOUNDARY ʌ d m ɪ n ɪ s t ɹ eɪ ʃ ə n WORD_BOUNDARY f ə ɹ ð ə WORD_BOUNDARY t ɹ iː t m ə n t WORD_BOUNDARY ʌ v WORD_BOUNDARY p ɑ ɹ k ɪ n s ə n z WORD_BOUNDARY ɪ n WORD_BOUNDARY t uː WORD_BOUNDARY θ aʊ z ə n d WORD_BOUNDARY t uː WORD_BOUNDARY d iː b iː ɛ s WORD_BOUNDARY k æ ɹ i z WORD_BOUNDARY ð ə WORD_BOUNDARY ɹ ɪ s k s WORD_BOUNDARY ʌ v WORD_BOUNDARY m eɪ d̠ʒ ə ɹ WORD_BOUNDARY s ɜː d̠ʒ ə ɹ ɹ i WORD_BOUNDARY w ɪ ð WORD_BOUNDARY ʌ WORD_BOUNDARY k ɑ m p l ɪ k eɪ ʃ ə n WORD_BOUNDARY ɹ eɪ t WORD_BOUNDARY ɹ ɪ l eɪ t ɪ d WORD_BOUNDARY t ə WORD_BOUNDARY ð ɪ WORD_BOUNDARY ɛ k s p iə ɹ ɪ ə n s WORD_BOUNDARY ʌ v ð ə WORD_BOUNDARY s ɜː d̠ʒ ɪ k ə l WORD_BOUNDARY t iː m WORD_BOUNDARY ð ə WORD_BOUNDARY m eɪ d̠ʒ ə ɹ WORD_BOUNDARY k ɑ m p l ɪ k eɪ ʃ ə n z WORD_BOUNDARY ɪ ŋ k l uː d WORD_BOUNDARY h ɛ m ə ɹ ɹ ɪ d̠ʒ WORD_BOUNDARY w ʌ n WORD_BOUNDARY t uː WORD_BOUNDARY p ə ɹ s ɛ n t WORD_BOUNDARY æ n d WORD_BOUNDARY ɪ n f ɛ k ʃ ə n WORD_BOUNDARY θ ɹ iː WORD_BOUNDARY f aɪ v WORD_BOUNDARY p ə ɹ s ɛ n t WORD_BOUNDARY